Skip to content
Review Open access

Artificial intelligence algorithms for the prediction of cognitive decline and dementia: A theoretical–historical narrative review

Sep 2026 · Journal of Alzheimer's Disease Reports · 0 citations · 35 references

TL;DR

Overall, artificial intelligence has substantially advanced prediction research in cognitive decline and dementia, but its routine clinical adoption will depend on more rigorous validation, improved transparency, and stronger integration between neuroscience, clinical practice, and data science.

Abstract

Population aging has increased the prevalence of neurodegenerative disorders associated with dementia, with Alzheimer's disease remaining the leading cause worldwide. Early identification of individuals at risk of cognitive decline, particularly those with mild cognitive impairment, remains a major clinical and scientific challenge. In this context, artificial intelligence has emerged as a promising framework for prognostic modeling and for the identification of clinically relevant predictors of disease onset and progression. This narrative review provides a theoretical and historical synthesis of the main machine learning and deep learning approaches used to predict cognitive decline and dementia from multimodal data, including biomarkers, clinical and demographic variables, cognitive measures, and neuroimaging markers. The review examines the methodological evolution of the field, from traditional statistical approaches to ensemble methods and deep neural architectures, and discusses the growing role of multimodal and longitudinal data integration. It also highlights major unresolved issues, including limited external validation, reduced interpretability, restricted generalizability, and the gap between predictive performance and clinical implementation. Overall, artificial intelligence has substantially advanced prediction research in cognitive decline and dementia, but its routine clinical adoption will depend on more rigorous validation, improved transparency, and stronger integration between neuroscience, clinical practice, and data science.

Read PDF

Similar papers

Open access Sep 2026

Modelling the risk of conversion from mild cognitive impairment to Alzheimer’s disease using machine learning

Mild cognitive impairment (MCI) is a transitional state between normal aging and dementia, characterized by subtle cognitive decline. While not all individuals with MCI will progress to Alzheimer’s disease (AD), early identification of those at high risk is crucial for timely interventions. Machine learning algorit...

A. Mouiha, Mohamed Taiebine, Jaouad El-Hilaly · 0 citations
Open access Sep 2026

A Machine Learning Framework for Binary and Multiclass Classification of Cognitive Impairment Using Structural MRI Biomarkers

The findings support the potential role of structural MRI biomarkers combined with interpretable ML approaches for the classification of cognitive impairment and the integration of demographic variables improved model performance, particularly in binary discrimination tasks, whereas multiclass classification remained m...

Alessia Venuto, Ambra Faraci, Alessandro Grimaldi et al. · 0 citations
Open access Sep 2026

Explainable Multimodal Deep Learning Framework for Longitudinal Prediction of Neurodegenerative Disease Progression with Clinical Validation

Neurodegenerative diseases, particularly Alzheimer's Disease and Parkinson's Disease, are rapidly increasing as one of the leading causes of disability, cognitive decline, and death among the elderly population worldwide. Accurately predicting long-term disease progression remains a significant research challenge due t...

Md. Ariful Islam, Moloy Biswas, Alif Laila et al. · 0 citations
Review Open access Aug 2026

Artificial Intelligence for Early Detection of Alzheimer's Disease: A Comparative Review of Speech, Neuroimaging, and EEG Biomarkers

Alzheimer's disease (AD) is a chronic neurodegenerative disorder and the most common cause of dementia globally. Accurate and early diagnosis of AD is essential to enhance patient care and management, facilitate recruitment for clinical trials, and provide access to novel treatments at a stage when intervention may hav...

H. Barber · 0 citations
Review Open access Sep 2026

Artificial Intelligence for Alzheimer’s Disease Diagnosis: From Traditional Machine Learning to Large Language Models

This review synthesizes recent advances in AI-based AD diagnosis, tracing the evolution from traditional ML to DL and LLMs and particular emphasis is placed on the emerging role of LLMs in extracting disease-related information from speech and clinical narratives, integrating heterogeneous biomedical data sources, and...

Xia-Yao Guo, Yan-Qi Sun, Yang Chen et al. · 0 citations
Conference

Predicting Cognitive Decline in Healthy Adults using Structural MRI

Alzheimer’s disease (AD) is a progressive neurological disorder and the leading cause of dementia, affecting millions globally. As populations continue to age, AD prevalence is expected to rise significantly, placing substantial burdens on healthcare systems. Early detection of cognitive decline is essential, as interv...

Samaneh Rezaeimanesh, Mohammad Fili, Gui-Ping Hu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.